Loading verified market, valuation, and statement data.
2. Company Fundamentals
2.1 Competitiveness
| Metric |
Value |
| Operating Margins |
16.96% |
| Profit Margins |
9.15% |
| Return on Equity |
43.88% |
| Return on Assets |
9.09% |
| Free Float |
1.36B |
| Dividend Yield |
4.19% |
| Short Int % Utilisation |
2.04% |
2.2 Growth
| Metric |
Value |
| Revenue Growth |
8.5% |
| Free Cash Flow |
8.75B |
| EBITDA |
12.8 (Ratio) |
| Enterprise Value |
239.3B |
| EV/Revenue |
2.51 |
| EV/EBITDA |
12.8 |
Revenue growth of 8.5% indicates steady, moderate expansion.
2.3 Management
| Role |
Metric |
| Consensus Rating |
N/A |
2.4 Return
| Metric |
Value |
| Expected Return (Ann.)* |
-0.51% |
| Risk / Std Dev (Ann.)* |
21.17% |
| 1-Year Price Return* |
-2.68% |
Latest Market Data (as of 2026-08-14, US Eastern time):
| Metric |
Value |
| Last Price |
$140.79 |
| 52-Week Range |
$133.73 – $171.48 |
| Observation Count |
251 trading days |
The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.
2.5 FCFF DCF Valuation
Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.
Step 1 — Forecast Operating Profit and NOPAT
| Reported operating input |
Value |
| Revenue |
$93.92B |
| Prior annual revenue |
$91.85B |
| EBIT |
$11.37B |
| Tax rate |
19.03% |
| NOPAT = EBIT × (1 − tax rate) |
$9.20B |
| Forecast start-growth basis |
2.25% |
| Forecast policy |
latest reported annual revenue growth, bounded to -10.00% / 15.00% |
Step 2 — Calculate FCFF
| Current FCFF building block |
Value |
| NOPAT |
$9.20B |
| Add: depreciation & amortisation |
$4.18B |
| Less: capital expenditure |
-$4.42B |
| Less/(add): working-capital cash-flow movement |
-$1.65B |
| Current unlevered FCFF |
$7.32B |
Explicit FCFF forecast
| Forecast year |
Revenue growth |
NOPAT |
D&A |
Capex |
Change in NWC |
FCFF |
Present value |
| 1 |
2.25% |
$9.41B |
$4.27B |
-$4.51B |
-$1.68B |
$7.49B |
$7.28B |
| 2 |
2.32% |
$9.63B |
$4.37B |
-$4.56B |
-$1.72B |
$7.72B |
$7.10B |
| 3 |
2.38% |
$9.86B |
$4.48B |
-$4.60B |
-$1.76B |
$7.97B |
$6.94B |
| 4 |
2.44% |
$10.10B |
$4.58B |
-$4.65B |
-$1.80B |
$8.23B |
$6.77B |
| 5 |
2.50% |
$10.35B |
$4.70B |
-$4.70B |
-$1.85B |
$8.50B |
$6.62B |
Step 3 — Determine the Discount Rate (WACC)
| WACC input |
Value |
| Risk-free rate |
4.71% |
| Equity risk premium assumption |
5.50% |
| Beta |
0.36 |
| Cost of equity |
6.70% |
| Pre-tax cost of debt |
2.36% |
| WACC |
5.71% |
| WACC validation |
requires assumption review |
Step 4 — Estimate Terminal Value
| Terminal-value input |
Value |
| Perpetuity growth rate |
2.50% |
| Terminal value |
$271.58B |
| Implied terminal EV / EBITDA |
15.54x |
| Terminal value as % of enterprise value |
85.56% |
Step 5 — Discount Cash Flows to Enterprise Value
| Enterprise-value component |
Value |
| Present value of explicit FCFF |
$34.72B |
| Present value of terminal value |
$205.76B |
| Indicated enterprise value |
$240.48B |
| Discounting convention |
mid-year for explicit FCFF; terminal value discounted at year-end five |
Step 6 — Convert Enterprise Value to Equity Value
| Equity bridge |
Value |
| Indicated enterprise value |
$240.48B |
| Less: gross interest-bearing debt |
$49.90B |
| Add: cash and equivalents |
$9.53B |
| Add: affiliate investments |
$0.00 |
| Less: minority interests |
$141.00M |
| Indicated common equity value |
$199.96B |
Step 7 — Calculate Indicative Value Per Share
| Per-share output |
Value |
| Shares used |
1,373,000,000.00 |
| Share-count basis |
reported diluted weighted-average shares |
| Current market price |
$140.18 |
| DCF indicative value per share |
$145.64 |
| Indicative value vs. market price |
3.90% |
Model Integrity Checks
| Check |
Result |
| Perpetuity growth is below the risk-free rate |
pass |
| Perpetuity growth is below WACC |
pass |
| WACC is within the configured operating-company range |
review required |
| Terminal-year FCFF is positive |
pass |
| Terminal capex converges to D&A |
pass |
| Terminal-value concentration |
within review band |
| Implied price differs from spot by more than 30% |
within review band |
2.6 Investor-Style Research Screen
| Educational screen |
Result |
| Buffett-inspired cash-quality checks |
4/4 evidenced checks |
| Lynch-inspired balance-and-growth checks |
4/4 evidenced checks |